Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MET mRNA | decreases expression | 19933214
|
C478479 |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) affects the activity of MET protein mutant form | affects activity | 18632630
|
C478479 |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] | decreases reaction|increases phosphorylation | 18632630
|
C478479 |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) results in decreased phosphorylation of and results in decreased activity of MET protein | decreases activity|decreases phosphorylation | 18632630
|
C478479 |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide inhibits the reaction [MET protein mutant form results in decreased susceptibility to ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)] | decreases reaction|decreases response to substance | 18632630
|
C478479 |
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) |
MET protein mutant form results in decreased susceptibility to ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide) | decreases response to substance | 18632630
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of MET mRNA | decreases expression | 17640349
|
C498826 |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide |
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide inhibits the reaction [MET protein mutant form results in decreased susceptibility to ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)] | decreases reaction|decreases response to substance | 18632630
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MET mRNA | affects expression | 17562736
|
C430898 |
AGN 194204 |
AGN 194204 results in decreased expression of MET protein | decreases expression | 15318936
|
C103303 |
alitretinoin |
alitretinoin results in increased phosphorylation of MET protein | increases phosphorylation | 16192631
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of MET mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of MET mRNA | decreases expression | 19769630 20458559
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of MET mRNA | increases expression | 12839939
|
D017638 |
Asbestos, Crocidolite |
FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of MET mRNA] | increases expression|increases reaction | 12839939
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of MET mRNA | increases expression | 12839939
|
D017638 |
Asbestos, Crocidolite |
FOSL1 protein promotes the reaction [Asbestos, Crocidolite results in increased expression of MET mRNA] | increases expression|increases reaction | 12839939
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MET mRNA | decreases expression | 20889680
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MET mRNA | decreases expression | 20889680
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MET protein | decreases expression | 20889680
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MET mRNA | decreases expression | 19150397
|
C053541 |
bicalutamide |
bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 17371283 11139396
|
C002791 |
bismuth tripotassium dicitrate |
bismuth tripotassium dicitrate results in increased expression of MET mRNA | increases expression | 15912405
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of MET mRNA | increases expression | 19371625
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MET mRNA | decreases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased phosphorylation of and results in decreased activity of MET protein | decreases activity|decreases phosphorylation | 17976157
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of MET mRNA | increases expression | 17484886
|
D002251 |
Carbon Tetrachloride |
MET protein affects the reaction [Carbon Tetrachloride results in increased expression of SPP1 protein] | affects reaction|increases expression | 15070743
|
D002251 |
Carbon Tetrachloride |
[Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of MET mRNA | affects cotreatment|decreases expression | 17069928
|
D002251 |
Carbon Tetrachloride |
[Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of MET protein | affects cotreatment|decreases expression | 17069928
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in decreased expression of MET mRNA | decreases expression | 12832660
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of MET mRNA | increases expression | 17009398
|
C031662 |
CB 3717 |
CB 3717 inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
C031662 |
CB 3717 |
CB 3717 results in increased expression of MET mRNA | increases expression | 11139396 17371283
|
C031662 |
CB 3717 |
Testosterone inhibits the reaction [CB 3717 results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D002509 |
Cephaloridine |
Cephaloridine results in increased expression of MET mRNA | increases expression | 18172885
|
D003042 |
Cocaine |
Cocaine affects the expression of MET mRNA | affects expression | 15681117
|
C014347 |
decitabine |
decitabine results in decreased expression of MET mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of MET mRNA] | affects reaction|decreases expression | 19363521
|
D004052 |
Diethylnitrosamine |
CTNNB1 protein promotes the reaction [Diethylnitrosamine results in decreased expression of MET protein] | decreases expression|increases reaction | 20583210
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of MET protein | decreases expression | 20583210
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP13A4 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ATP2A1 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CTSC mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DBP mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of GADD45B mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of GKN3 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of H2-D1 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of IFITM5 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ITPKB mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of KRT13 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of LANCL1 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of MS4A1 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of OLFR771 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of PLA2G2C mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of SLC22A4 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of TSGA10 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of ZFP3 mRNA] | decreases expression|decreases reaction | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ABCA3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ABTB2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ACO2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AFM mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AGXT mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AHSA1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of AP2B1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARG1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP19 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP5 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGEF19 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARL5A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASB14 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASNS mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATP11C mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATP8B4 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of B2M mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of B3GAT1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of BCKDHB mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of BST2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of C1QC mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CAPZA2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDK2AP2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CIB3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CLOCK mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CML5 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of COL6A1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CPEB2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CTSS mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYB5 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP2D13 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP2D22 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP3A13 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP3A44 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CYP4F16 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DCT mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DGUOK mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DUSP1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DYNLT1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of EPOR mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of EVI2B mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of EXOC8 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of FAM20B mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of G6PC mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GADD45G mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GBP9 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GFER mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GIMAP7 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GLO1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GSTM2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of H19 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of H2-BL mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HIRA mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HNRPC mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HSD17B11 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HSPA1B mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HSPD1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of HTR2A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ID3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of IGF1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of IGFBP1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of KCNAB1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of KCNJ14 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of KLF10 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of KLF12 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of LRP1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of LRRC68 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MALAT1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MEGF9 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MUG1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MUG2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NAT8 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NDRG1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NDUFA12 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NDUFA7 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NKX6-2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NLRP3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NPR2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NRN1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of OAT mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of OLFM1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of OLFR203 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of OLFR677 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of P2RX4 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of P2RX7 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PALMD mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PARD6A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PEBP1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PIGR mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLA1A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLA2G16 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLA2G2C mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PNRC1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PPM1K mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RAB6B mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RABGAP1L mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RBBP4 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RBP1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RHOH mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL17 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL27A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL32 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL35 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL41 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of RPL9 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SBP mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SCD2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SCGB1C1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SCN8A mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SCTR mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SERF2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SH2D6 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC16A10 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC19A2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC25A48 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SLC47A1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SMOX mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SOD1 protein] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ST7 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SYT5 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TCEB2 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TLN1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TMEM98 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TMPRSS3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TMSB4X mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRAPPC5 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRPM1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UBC mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UGT2B1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of UTRN mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of VEPH1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of VIM mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of VSIG10 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of VSIG4 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of WWOX mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ZCCHC18 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ZFP300 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ZFP36L1 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ZZZ3 mRNA] | decreases reaction|increases expression | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of EGFR protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK1 protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of MAPK3 protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCA protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein inhibits the reaction [Diethylnitrosamine results in increased phosphorylation of and results in increased activity of PRKCB protein] | decreases reaction|increases activity|increases phosphorylation | 17942915
|
D004052 |
Diethylnitrosamine |
MET protein results in increased susceptibility to Diethylnitrosamine | increases response to substance | 17942915
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of MET mRNA | increases expression | 19371625
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine affects the expression of MET mRNA | affects expression | 16596271
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of MET protein | decreases expression | 16109756 18083897
|
D004317 |
Doxorubicin |
HGF protein inhibits the reaction [Doxorubicin results in decreased expression of MET protein] | decreases expression|decreases reaction | 16109756 18083897
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] | decreases reaction|increases phosphorylation | 19244381
|
C010452 |
estradiol-17 beta-benzoate |
estradiol-17 beta-benzoate affects the expression of MET mRNA | affects expression | 15059950
|
D004958 |
Estradiol |
Estradiol results in increased expression of MET mRNA | increases expression | 17640349
|
C015854 |
estradiol valerate |
estradiol valerate results in decreased expression of MET mRNA | decreases expression | 15972882
|
D000431 |
Ethanol |
Ethanol results in increased expression of MET mRNA | increases expression | 15353170 16946407
|
D015025 |
Zearalenone |
Zearalenone results in increased expression of MET mRNA | increases expression | 19371625
|
D005492 |
Folic Acid |
Folic Acid inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D005492 |
Folic Acid |
Folic Acid results in increased expression of MET mRNA | increases expression | 11139396
|
D005492 |
Folic Acid |
Testosterone inhibits the reaction [Folic Acid results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D019833 |
Genistein |
Genistein results in increased expression of MET mRNA | increases expression | 19371625
|
C006552 |
kaempferol |
kaempferol inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] | decreases reaction|increases phosphorylation | 19244381
|
D007854 |
Lead |
Lead results in decreased expression of MET protein | decreases expression | 17298174
|
C008261 |
lead acetate |
lead acetate results in decreased expression of MET protein | decreases expression | 17298174
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in decreased expression of MET protein | decreases expression | 17298174
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in increased expression of MET mRNA | increases expression | 12634122
|
C040015 |
myricetin |
myricetin inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] | decreases reaction|increases phosphorylation | 19244381
|
C484027 |
oligofectamine |
oligofectamine results in increased expression of MET mRNA | increases expression | 14668052
|
C016340 |
o,p'-DDT |
o,p'-DDT results in increased expression of MET mRNA | increases expression | 19371625
|
D010269 |
Paraquat |
Paraquat results in decreased expression of MET protein | decreases expression | 17298174
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of MET mRNA | increases expression | 19270015 19363144
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MET mRNA | increases expression | 18301758
|
D010972 |
Platelet Activating Factor |
Platelet Activating Factor results in decreased expression of MET mRNA | decreases expression | 15307983
|
C443641 |
poly(propyleneimine) |
poly(propyleneimine) analog affects the expression of MET mRNA | affects expression | 16308212
|
D011794 |
Quercetin |
Quercetin inhibits the reaction [HGF protein results in increased phosphorylation of MET protein] | decreases reaction|increases phosphorylation | 19244381
|
C037219 |
quinoline |
quinoline analog results in decreased activity of MET protein | decreases activity | 17964000
|
C059514 |
resveratrol |
resveratrol results in increased expression of MET mRNA | increases expression | 19371625
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of MET mRNA | increases expression | 16772331
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of MET mRNA | decreases expression | 16882884
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of MET mRNA | affects expression | 16507464
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MET mRNA | increases expression | 16876216 11241755
|
C025462 |
sulindac sulfide |
sulindac sulfide inhibits the reaction [CTNNB1 protein results in increased expression of MET protein] | decreases reaction|increases expression | 14710233
|
D013739 |
Testosterone |
bicalutamide inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396 17371283
|
D013739 |
Testosterone |
CB 3717 inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D013739 |
Testosterone |
Folic Acid inhibits the reaction [Testosterone results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D013739 |
Testosterone |
Testosterone inhibits the reaction [CB 3717 results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D013739 |
Testosterone |
Testosterone inhibits the reaction [Folic Acid results in increased expression of MET mRNA] | decreases reaction|increases expression | 11139396
|
D013739 |
Testosterone |
Testosterone results in increased expression of MET mRNA | increases expression | 11139396 17371283
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MET mRNA | increases expression | 20067830
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MET mRNA | decreases expression | 19933214
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MET mRNA | increases expression | 16051641
|
C025643 |
vinclozolin |
vinclozolin affects the expression of MET mRNA | affects expression | 19015723
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of MET mRNA | decreases expression | 18220299
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
10.86 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
10.86 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
10.86 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
8.51 | 18287403 |
MESH:D000138 |
Acidosis |
|
Ethanol |
8.51 | 11192467 |
MESH:D058186 |
Acute Kidney Injury |
|
Folic Acid |
7.26 | 16595132 16316344 17003819 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.26 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.58 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
14.60 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
14.60 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
14.60 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
14.60 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
14.60 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
14.60 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
17.11 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
17.11 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
17.11 | 19555203 |
MESH:D000236 |
Adenoma |
|
Folic Acid |
17.11 | 16963246 |
MESH:D000236 |
Adenoma |
|
resveratrol |
17.11 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.02 | 17162532 19061943 16434500 19052882 18056438 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
20.02 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.02 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.02 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.10 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.30 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.19 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.98 | 21441931 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
4.71 | 15451039 15451040 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.14 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Folic Acid |
5.84 | 17116317 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
5.84 | 16183991 16162502 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
5.84 | 18759972 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.92 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.43 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.71 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.24 | 15513904 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.25 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
7.43 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
7.43 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.50 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.21 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
6.21 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.10 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
4.49 | 16516891 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.49 | 16456186 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.38 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
2.91 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 17053076 21328570 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.17 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Folic Acid |
2.17 | 21388746 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
9.16 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
9.16 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.84 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
17.59 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
17.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
17.59 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
17.59 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.19 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.36 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.10 | 14601052 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.33 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.70 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.30 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
14.36 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
14.36 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
14.36 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
14.36 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
14.36 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
14.36 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
14.36 | 19526202 15634643 15136595 16826403 16096432 18234424 17369602 17426702 16115903 15993339 18695136 15692762 17983394 16595493 11325840 16935488 18628466 15668708 16264153 18382427 15939500 15994142 16322301 15567936 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
14.36 | 12948864 14630087 17289903 16675129 18497071 17261762 19861407 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Folic Acid |
14.36 | 16777985 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
14.36 | 17200150 16873071 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
kaempferol |
14.36 | 16756079 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
14.36 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
14.36 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
14.36 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
14.36 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
14.36 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.00 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.78 | 11589617 |
MESH:D002056 |
Burns |
|
Ethanol |
4.07 | 16374292 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.94 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.87 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.20 | 16097048 16192424 16011737 15700767 16124888 15673190 16227642 3786805 18705752 15721981 16050911 10355542 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.21 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
6.77 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.77 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.55 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
35.45 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
35.45 | 15553829 16217749 11135700 14691202 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
35.45 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
35.45 | 16502159 19052882 17173139 21159647 16569478 17428255 18788625 3581430 20727157 20935162 18393292 11831363 16878318 18971187 16328049 16779866 19919837 10737359 16288022 19822196 16935385 18210153 17761372 16698587 19539802 18665156 10672840 20101231 17978847 16807293 17055752 20084675 20514400 17162532 20214788 20512989 19171122 19107877 19208518 19383236 17138121 19418558 19701751 16540662 18506893 19394651 18691550 19519916 16681979 20007298 18056438 18494052 20432363 18978308 19335982 16830150 3084413 20524982 18785209 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
35.45 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
35.45 | 16234567 18059187 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
35.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
35.45 | 15763234 15289165 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
35.45 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
35.45 | 17173139 1701930 20935162 6705139 20007298 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
35.45 | 19519916 12508355 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
35.45 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
35.45 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
35.45 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
35.45 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.39 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.00 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.21 | 12391285 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.38 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.27 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
marker/mechanism |
|
| |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.85 | 1485588 16201981 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.60 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
18.68 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
18.68 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
18.68 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
18.68 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
18.68 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
18.68 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
18.68 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
9.38 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
9.38 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
9.38 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.12 | 16242529 17131338 16455267 17329180 16731534 16364871 17382496 17007740 15811867 17351982 16278810 17519947 15792986 16109756 16612575 15505089 17924179 17308081 17974986 18627295 17928571 16651473 16952015 15476868 16269455 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.71 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Folic Acid |
13.93 | 16755160 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
13.93 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
kaempferol |
13.93 | 16756079 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
13.93 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
5.98 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
5.98 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.62 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
16.62 | 17174075 2727394 7505956 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.62 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
16.62 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.62 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.67 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.00 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.43 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.65 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.65 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.38 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.55 | 16461808 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
6.74 | 15513904 |
MESH:D002971 |
Cleft Lip |
|
Folic Acid |
6.74 | 21254359 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
11.77 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Folic Acid |
11.77 | 21254359 8946559 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
11.77 | 8697196 15340226 16354765 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
11.77 | 9407595 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.12 | 19606084 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.71 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
7.71 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
7.09 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
7.09 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
7.09 | 15741050 17148506 16640504 19056647 19440933 11134977 17191121 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.09 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
7.32 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
7.32 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
7.32 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Folic Acid |
7.32 | 17116713 17245555 16985020 17087956 16963246 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
7.32 | 18095365 18852136 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
7.32 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.56 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.35 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.62 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
10.35 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
10.35 | 11198716 15451040 10194807 19302082 11873399 15451039 15513904 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Lead |
10.35 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
10.35 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
10.35 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
10.35 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
10.35 | 14991402 10589399 9142499 16925845 9211117 8800419 9125849 17551590 9224671 9664655 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
9.50 | 16002989 12952375 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
9.50 | 14966744 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.55 | 15213294 |
MESH:D003704 |
Dementia |
|
Lead |
8.92 | 16140633 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
8.92 | 16140633 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.12 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
6.94 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.94 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
11.63 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
11.63 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Folic Acid |
11.63 | 16886840 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
11.63 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
11.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.35 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.35 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
18.34 | 16393943 19085960 11743745 14986274 17562736 10774834 16485898 16177239 12594235 11834606 19164858 18071297 18713872 11461765 12392966 19416960 19370779 16227642 2444490 12705907 11529661 17522070 12153990 15968718 19739265 17906064 12540782 16081117 10663392 11421492 14550746 10915739 11739529 11287661 15619225 16109766 19420014 12958197 19923254 14725611 16781746 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
18.34 | 7120509 15968718 15027814 2869522 3732212 21278145 9327722 16227642 4309450 16177239 17522070 7440962 6623471 19085960 15998439 10915739 6884620 10092053 11566570 3786805 19336974 7179309 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
18.34 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
18.34 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
18.34 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
18.34 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
18.34 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
18.34 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.49 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.61 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.61 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.46 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
8.41 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
8.41 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
8.41 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
9.94 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
9.94 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.47 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.51 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.93 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.93 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
28.83 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
28.83 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
28.83 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
28.83 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Folic Acid |
28.83 | 17301261 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
28.83 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
28.83 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.51 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.55 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.27 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.53 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.27 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.56 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.04 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.67 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.43 | 3659116 |
MESH:D007172 |
Erectile Dysfunction |
|
estradiol valerate |
5.26 | 14972507 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.51 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.74 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
11.74 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
11.74 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
11.74 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
11.74 | 16704527 |
MESH:D020329 |
Essential Tremor |
|
Lead |
5.34 | 14594619 18007985 |
MESH:D017889 |
Exfoliation Syndrome |
|
Folic Acid |
4.90 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.33 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.33 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
19.06 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
19.06 | 15959796 16045604 12631006 61145 12795759 17595544 16239168 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
19.06 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
19.06 | 19236843 16409862 18620774 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.06 | 19236843 20131406 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.06 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.27 | 16002989 16611131 15751030 16513791 16534752 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
4.71 | 15451040 16946407 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.88 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
Lead |
9.84 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
9.84 | 19769572 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.00 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
16.45 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
16.45 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.45 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
16.45 | 17994277 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.25 | 7506515 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.70 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
15.62 | 16983495 |
MESH:D005756 |
Gastritis |
|
Ethanol |
15.62 | 15046732 |
MESH:D005756 |
Gastritis |
|
Folic Acid |
15.62 | 17171786 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.34 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.70 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.85 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.85 | 16452187 |
MESH:D005901 |
Glaucoma |
|
Folic Acid |
4.53 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
22.51 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
22.51 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
myricetin |
22.51 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
22.51 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
22.51 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
22.51 | 17312396 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.79 | 17643826 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.56 | 11124998 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.53 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.99 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
10.57 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
10.57 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
10.57 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.55 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
13.17 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Folic Acid |
13.17 | 17286298 16524890 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
13.17 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
13.17 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.06 | 17875725 14766674 17888722 16879835 16707910 16244372 18674790 16495754 16244371 16144979 12587719 18006777 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.76 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.76 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
5.30 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
7.86 | 15692506 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
7.86 | 598648 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.04 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
11.06 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.06 | 19176532 16221962 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.06 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.43 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.59 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.05 | 17019078 |
MESH:D006679 |
HIV Seropositivity |
|
Folic Acid |
4.90 | 17209195 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
5.83 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
5.83 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.15 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.44 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
10.33 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
10.33 | 18783367 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
10.33 | 16870215 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.70 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.94 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.48 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
3.99 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
kaempferol |
12.81 | 18262572 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
12.81 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
12.81 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Folic Acid |
3.99 | 16395265 16865747 16397167 16755160 16433478 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.49 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.86 | 14722030 12960047 |
MESH:D006973 |
Hypertension |
|
Quercetin |
4.35 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.35 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.51 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.78 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.15 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.60 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
4.00 | 16002989 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.25 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.07 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.79 | 15036965 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
16.76 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Lead |
16.76 | 16780224 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
16.76 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
16.76 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
16.76 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
6.37 | 18785209 |
MESH:D007249 |
Inflammation |
|
resveratrol |
6.37 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
6.37 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.19 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.19 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
9.95 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
9.95 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
9.95 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.19 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
14.10 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
14.10 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
14.10 | 15992940 17551590 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.38 | 17086741 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.04 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
15.15 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
15.15 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
15.15 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
15.15 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
15.15 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.62 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
5.94 | 14681315 15003126 16762066 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
5.94 | 15610895 |
MESH:D007855 |
Lead Poisoning |
|
Lead |
5.34 | 16700817 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
12.96 | 17184923 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
12.96 | 15451040 |
MESH:D007859 |
Learning Disorders |
|
Lead |
12.96 | 16384672 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
20.37 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
20.37 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
20.37 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
kaempferol |
20.37 | 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
20.37 | 17468513 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
20.37 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.55 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.26 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.71 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.98 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
12.93 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
12.93 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
12.93 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.29 | 16467208 17050201 19850784 20471514 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.29 | 17679729 19387464 18704418 18206229 19010910 18460780 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.29 | 16294345 17596541 19850784 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.86 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.41 | 12712474 17217047 9834237 17869043 15748426 12018890 17649720 19225113 19642359 16966277 17712046 15213294 19035177 16330433 16823087 15622746 16331271 15336539 16112521 12679006 11468182 16891316 17107899 11161223 19075265 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.41 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.41 | 16891316 17506722 17294898 16766008 19642359 15748426 16823087 17301526 17339181 19029980 9834237 17368321 17649720 19225113 17107899 16331271 17712046 19075265 17217047 12679006 19035177 16140955 16788101 16935935 17361223 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.79 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.14 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
6.85 | 17676605 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
6.85 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
12.84 | 16943688 21278145 17157831 17334410 11408273 11903743 17174718 16239168 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
12.84 | 20032147 19638242 18522880 18407596 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
12.84 | 15289165 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
12.84 | 21047994 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.50 | 18295389 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
18.36 | 18395914 15893842 17708605 18705752 12958196 12667390 17766677 18429990 16248980 15362042 12632514 14716833 17922224 18263696 17714472 15959796 15925388 18156304 14512876 15057751 14748882 17976157 18412020 18481824 12649538 18339082 12546737 17525996 12632512 16011737 12666154 18166357 15338365 18418968 17631135 18420326 17698563 18395095 16192424 18054572 18006644 18317297 17761835 15876570 15370692 12586293 12389079 17640975 18251166 12445421 17481882 15123356 15931870 16097048 18376398 17900296 14716496 16116963 15730626 17565644 17869086 14724832 12445418 18279442 16638106 12741479 15673190 17944888 17805973 15650968 18210741 10355542 15818738 16033810 14620537 12609069 16136751 17721639 17823541 18205269 17557913 15052691 12898905 11481614 18472094 16015684 18277467 15996030 18187930 20821823 18472332 16027843 13678700 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
18.36 | 15744066 16627068 16603200 18672772 16544323 15383259 15138612 14709902 16570917 15298665 15591649 17201889 18567088 15492853 17198567 14568256 18637143 16270385 15571005 16042886 15577212 14726149 15723089 17640959 17203207 15067225 17724770 15842777 18629640 17465448 16009107 17348192 15793283 15366600 15798949 15864749 15161499 15942678 18239293 14659978 15504291 15099470 14643895 15086199 16169303 15479170 17534399 12925901 15339415 12918455 18210741 15369754 15733078 18364076 17036385 17666798 18237412 15763062 18095165 18371158 15081153 17881167 17719030 17196135 17432682 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
18.36 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
18.36 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
18.36 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
18.36 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
18.36 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
18.36 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
18.36 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
18.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
18.36 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
10.42 | 12969438 11587558 19014921 12587719 19784758 16610002 19460945 16611625 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
10.42 | 15720792 16246199 15830285 17285989 16964402 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
10.42 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Folic Acid |
10.42 | 16877991 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
10.42 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.07 | 17207112 17347304 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.59 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
13.27 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
13.27 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
13.27 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
36.31 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
36.31 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
36.31 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
36.31 | 20583210 15175105 19833225 12771043 18754104 20452335 19073162 18644402 19090486 19690152 20434301 19638242 9163691 19426721 19256749 19294768 19551842 18648771 16942905 19812893 21047994 20137499 19996281 18977376 19850985 19642983 15885732 19499222 19255062 20101389 19427195 21071580 20405173 12112319 20492335 19254457 21167192 21278145 10737359 2862719 20118626 20501860 2422723 18978307 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
36.31 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
36.31 | 3113478 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
36.31 | 19482888 19812893 8742319 15975961 21047994 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
36.31 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
36.31 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
36.31 | 20405173 19073162 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
36.31 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
36.31 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
26.38 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
26.38 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
26.38 | 9362446 18282651 18775883 17854601 19539802 3124819 18079962 2563599 19009564 18308698 18544905 21159647 19519916 19126423 16267830 18164116 19004024 18253720 17174075 16842330 18093689 17942915 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
26.38 | 1848544 6150874 15603536 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
26.38 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
26.38 | 17172636 18308698 6150874 2563599 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
26.38 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
26.38 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.89 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.76 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.45 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
13.34 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
13.34 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
13.34 | 6695378 20464547 20135361 18569708 18520028 18816296 20869020 17053015 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
13.34 | 20970405 20512841 21163286 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
13.34 | 16061637 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
13.34 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
13.34 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
13.34 | 16712894 15276417 17306315 19931552 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
13.34 | 19555203 11884234 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Folic Acid |
3.14 | 17718048 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.56 | 15166399 |
MESH:D008223 |
Lymphoma |
|
decitabine |
10.10 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
10.10 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
10.10 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.75 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.26 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
7.26 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
3.99 | 15621674 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.91 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.66 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.01 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.01 | 11408345 16891317 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
11.01 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
11.01 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.88 | 19453300 |
MESH:D019767 |
Maxillofacial Abnormalities |
|
Folic Acid |
5.10 | 16832597 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.52 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
10.64 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
10.64 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
10.64 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
resveratrol |
10.64 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
10.64 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
10.64 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
2.99 | 19513568 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
13.03 | 18411066 15451040 |
MESH:D008569 |
Memory Disorders |
|
Lead |
13.03 | 17263510 16384672 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
13.03 | 18436314 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.85 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
5.52 | 18303189 16966607 16166281 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.52 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.84 | 17112576 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
5.30 | 17671175 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.96 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.73 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
4.78 | 18436314 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.20 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.65 | 19417148 11468182 19549372 15949261 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
9.65 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
9.65 | 17164350 16490592 14749477 16267019 17935668 17049120 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
10.66 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.66 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.93 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.32 | 18186108 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.07 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
10.21 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
10.21 | 18608210 16882708 19157545 19010910 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
10.21 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
18.73 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
18.73 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
18.73 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
18.73 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
18.73 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
18.73 | 17188708 16317513 17125593 16525036 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.42 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.42 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.49 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.49 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
16.49 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.49 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.17 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.88 | 17484760 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.40 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
8.12 | 3581430 9029167 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
8.12 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
8.12 | 598648 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
22.64 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
22.64 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
22.64 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
22.64 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
22.64 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
22.64 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
22.64 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
22.64 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.32 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.32 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.14 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.19 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.50 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.26 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
31.01 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
31.01 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
31.01 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
31.01 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
31.01 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
31.01 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
18.48 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Folic Acid |
18.48 | 17438019 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
18.48 | 10525206 18186108 11749123 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
18.48 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
18.48 | 9142499 |
MESH:D009447 |
Neuroblastoma |
marker/mechanism |
|
| 16051641 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.93 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
11.23 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
11.23 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
11.23 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.88 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.88 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.51 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Folic Acid |
3.96 | 16322990 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.64 | 20558911 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.77 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.39 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
kaempferol |
6.39 | 16756079 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
13.74 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
13.74 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
13.74 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.63 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.39 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
19.41 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
19.41 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
19.41 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
19.41 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
19.41 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
19.41 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
19.41 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.00 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.00 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
20.97 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
20.97 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
20.97 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
20.97 | 12384795 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
20.97 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
20.97 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
20.97 | 15976015 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.61 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.57 | 15824117 11124998 11445065 16140633 15451049 16510128 12911755 11181820 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.85 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.64 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.55 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.57 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.09 | 16977796 15687265 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.31 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.55 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
3.86 | 12504350 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.40 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.00 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
12.47 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
12.47 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
12.47 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
36.53 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
36.53 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Lead |
36.53 | 16384672 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
36.53 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
36.53 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
36.53 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
36.53 | 19015723 18220299 18042343 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.15 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.34 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
14.97 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
14.97 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
14.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
AGN 194204 |
4.49 | 16000583 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
4.49 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
4.49 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
4.49 | 18487222 19240160 15638997 17914592 19011039 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
4.49 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.49 | 17136230 15846301 15046698 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
4.49 | 16868541 18437689 15749863 15897917 16888761 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
4.49 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
4.49 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
4.49 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
4.49 | 15767336 17675339 17718901 17804756 16731767 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
4.49 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.34 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.06 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
3.89 | 12752131 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.38 | 16134406 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.20 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.19 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.02 | 15814490 17365031 17322281 17975199 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
5.02 | 17997886 16324872 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
8.60 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Folic Acid |
8.60 | 15728788 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.98 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.49 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.49 | 15827377 17520802 17058453 16314181 16317513 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.36 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.48 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.41 | 16458197 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
9.13 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.13 | 16116481 16283617 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.47 | 16767912 18313854 15625365 15675481 17710206 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.41 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
8.41 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.20 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.94 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Folic Acid |
2.81 | 16641680 |
MESH:D012640 |
Seizures |
|
Cocaine |
7.68 | 10454489 |
MESH:D012640 |
Seizures |
|
Ethanol |
7.68 | 9754883 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
7.68 | 3137016 4039156 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.23 | 6407741 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.60 | 16631401 |
MESH:D012871 |
Skin Diseases |
|
Folic Acid |
3.07 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.38 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
22.38 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
22.38 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
22.38 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
22.38 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.38 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
22.38 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.99 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
4.11 | 16002989 16709447 |
MESH:D013118 |
Spinal Cord Diseases |
|
Folic Acid |
4.90 | 16361298 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.33 | 12854658 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.67 | 12587719 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
11.08 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
11.08 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
11.08 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
11.08 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
11.08 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
11.08 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Folic Acid |
11.08 | 17171786 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
11.08 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.03 | 17918041 17189318 11906479 9211565 16755016 9562338 |
MESH:D020521 |
Stroke |
|
Folic Acid |
3.85 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.96 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.40 | 16684133 16045194 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
3.74 | 9754883 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.30 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
22.09 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
22.09 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
22.09 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
22.09 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
22.09 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
22.09 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.08 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.19 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.19 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D014202 |
Tremor |
|
Lead |
4.89 | 21145352 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.84 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
19.95 | 11780464 12845720 20435036 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
19.95 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
19.95 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
19.95 | 16712894 16452187 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
19.95 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
19.95 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
19.95 | 11723127 17306315 16452187 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.44 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
18.40 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
18.40 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
18.40 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
18.40 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
11.81 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
11.81 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
13.01 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
13.01 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
13.01 | 18645019 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
10.82 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
10.82 | 16752155 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
3.86 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.83 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.99 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.42 | 17334414 16364871 17678736 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.42 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.49 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.64 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.46 | 16287080 |